Antifungal Properties of the Immunosuppressant FK-506: Identification of an FK-506-Responsive Yeast Gene Distinct from FKB1

References

• Balzi, E., W. Chen, S. Ulaszewski, E. Capieaux, and A. Goffeau. 1987. The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol. Chem. 262:16871–16879.
   PubMed Web of Science ®Google Scholar
• Bierer, B. E., P. S. Mattila, R. F. Standaert, L. A. Herzenberg, S. J. Burakoff, G. Crabtree, and S. L. Schreiber. 1990. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl. Acad. Sci. USA 87:9231–9235.
   PubMed Web of Science ®Google Scholar
• Birge, E. A., and C. G. Kurland. 1969. Altered ribosomal protein in streptomycin-dependent Escherichia coli. Science 166:1282–1284.
   PubMedGoogle Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Breckenridge, L., and L. Gorini. 1970. Genetic analysis of streptomycin resistance in Escherichia coli. Genetics 65:9–25.
   PubMed Web of Science ®Google Scholar
• Brizuela, L. Unpublished data.
   Google Scholar
• Chrebet, G., and S. A. Parent. Unpublished data.
   Google Scholar
• Diaz, L., M. Ehrenberg, and C. G. Kurland. 1986. How do combinations of rpsL- and miaA- generate streptomycin dependence? Mol. Gen. Genet. 202:207–211.
   PubMedGoogle Scholar
• Dreyfuss, M., E. Härri, H. Hofmann, H. Kobel, W. Pache, and H. Tscherter. 1976. Cyclosporin A and C. Eur. J. Appl. Microbiol. 3:125–133.
   Web of Science ®Google Scholar
• Dumont, F. J. (Merck Sharp and Dohme Research Laboratories). 1991. Personal communication..
   Google Scholar
• Dumont, F. J., M. R. Melino, M. J. Staruch, S. L. Koprak, P. A. Fischer, and N. H. Sigal. 1990. The immunosuppressive macrolides FK506 and rapamycin act as reciprocal antagonists in murine T cells. J. Immunol. 144:1418–1424.
   PubMed Web of Science ®Google Scholar
• Dumont, F. J., M. J. Staruch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J. Immunol. 144:251–258.
   PubMed Web of Science ®Google Scholar
• Falco, S. C., K. S. Dumas, R. E. McDevitt, and J. E. Golin. 1986. Molecular biology of sulfonylurea herbicide action on Saccharomyces cerevisiae, p. 99–104. In G. G. Stewart, L. Russell, R. D. Kelin, and R. R. Hiebsch (ed.), Biological research on industrial yeasts, vol. III. CRC Press, Boca Raton, Fla.
   Google Scholar
• Findlay, J. A., and L. Radics. 1980. On the chemistry and high field nuclear magnetic resonance spectroscopy of rapamycin. Can. J. Chem. 58:579–590.
   Web of Science ®Google Scholar
• Fischer, G., B. Wittmann-Liebold, K. Lang, T. Kiefhaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (London) 337:476–478.
   PubMed Web of Science ®Google Scholar
• Haendler, B., R. Keller, P. C. Hiestand, H. P. Kocher, G. Wegmann, and N. Rao Mowa. 1989. Yeast cyclophilin: isolation and characterization of the protein, cDNA and gene. Gene 83:39–46.
   PubMedGoogle Scholar
• Handschumacher, R. E., M. W. Harding, J. Rice, R. J. Drugge, and D. W. Speicher. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–547.
   PubMed Web of Science ®Google Scholar
• Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber. 1989. A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl-prolyl isomerase. Nature (London) 341:758–760.
   PubMed Web of Science ®Google Scholar
• Harwick, H. J., P. Weiss, and F. R. Fekety, Jr. 1968. Application of microtitration techniques to bacteriostatic and bactericidal antibiotic susceptibility testing. J. Lab. Clin. Med. 72:511–516.
   PubMedGoogle Scholar
• Kino, T., H. Hatanaka, M. Hashimoto, M. Nishiyama, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and H. Imanaka. 1987. FK506, a novel immunosuppressant isolated from a Streptomy- ces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 40:1249–1255.
   PubMed Web of Science ®Google Scholar
• Kino, T., H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Yajima, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and T. Ochiai. 1987. FK506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 40:1256–1265.
   PubMed Web of Science ®Google Scholar
• Koletsky, A. J., M. W. Harding, and R. E. Handschumacher. 1986. Cyclophilin: distribution and variant properties in normal and neoplastic tissues. J. Immunol. 137:1054–1059.
   PubMed Web of Science ®Google Scholar
• Kronke, M., W. J. Leonard, J. M. Depper, S. K. Arya, F. Wong-Staal, R. C. Gallo, T. A. Waldmann, and W. C. Greene. 1984. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. USA 81:5214–5218.
   PubMed Web of Science ®Google Scholar
• Lang, K., F. X. Schmid, and G. Fischer. 1987. Catalysis of protein folding by prolyl isomerase. Nature (London) 329:268–270.
   PubMed Web of Science ®Google Scholar
• Leppert, G., R. McDevitt, S. C. Falco, T. K. Van Dyk, M. B. Ficke, and J. Golin. 1990. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 125:13–20.
   PubMed Web of Science ®Google Scholar
• Martel, R. R., J. Klicius, and S. Galet. 1977. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can. J. Physiol. Pharmacol. 55:48–51.
   PubMed Web of Science ®Google Scholar
• Metcalfe, S. M., and F. M. Richards. 1990. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Transplantation 49:798–802.
   PubMed Web of Science ®Google Scholar
• Momose, H., and L. Gorini. 1971. Genetic analysis of streptomycin dependence in Escherichia coli. Genetics 67:19–38.
   PubMedGoogle Scholar
• Parent, S. A., and J. R. Thompson. Unpublished data.
   Google Scholar
• Rothstein, R. 1983. One-step gene disruption in yeast. Methods Enzymol. 101:202–211.
   PubMed Web of Science ®Google Scholar
• Ruusala, T., D. Andersson, M. Ehrenberg, and C. G. Kurland. 1984. Hyperaccurate ribosomes inhibit growth. EMBO J. 3:2575–2580.
   PubMed Web of Science ®Google Scholar
• Ruusala, T., and C. G. Kurland. 1984. Streptomycin preferentially perturbs ribosomal proofreading. Mol. Gen. Genet. 198:100–104.
   PubMedGoogle Scholar
• Saunders, G. W., and G. H. Rank. 1982. Allelism of pleiotropic drug resistance in Saccharomyces cerevisiae. Can. J. Genet. Cytol. 24:493–503.
   PubMedGoogle Scholar
• Sawada, S., G. Suzuki, Y. Kawase, and F. Takaku. 1987. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J. Immunol. 139:1797–1803.
   PubMed Web of Science ®Google Scholar
• Schneuwly, S., R. D. Shortridge, D. C. Larrivee, T. Ono, M. Ozaki, and W. L. Pak. 1989. Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein). Proc. Natl. Acad. Sci. USA 86:5390–5394.
   PubMed Web of Science ®Google Scholar
• Sherman, F., G. R. Fink, and J. B. Hicks. 1986. Laboratory course manual for methods in yeast genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Shevach, E. M. 1985. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 3:397–423.
   PubMed Web of Science ®Google Scholar
• Shieh, B.-H., M. A. Stamnes, S. Seavello, G. L. Harris, and C. S. Zuker. 1989. The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature (London) 338:67–70.
   PubMed Web of Science ®Google Scholar
• Siekierka, J. J., S. H. Y. Hung, M. Poe, C. Shirley Lin, and N. H. Sigal. 1989. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (London) 341:755–757.
   PubMed Web of Science ®Google Scholar
• Siekierka, J. J., M. J. Staruch, S. H. Y. Hung, and N. H. Sigal. 1989. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein cyclophilin. J. Immunol. 143:1580–1583.
   PubMedGoogle Scholar
• Siekierka, J. J., G. Wiederrecht, H. Greulich, D. Boulton, S. H. Y. Hung, J. Cryan, P. J. Hodges, and N. H. Sigal. 1990. The cytosolic-binding protein for the immunosuppressant FK- 506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase. J. Biol. Chem. 265:21011–21015.
   PubMedGoogle Scholar
• Sigal, N. H., J. J. Siekierka, and F. J. Dumont. 1990. Observations on the mechanism of action of FK-506. Biochem. Pharmacol. 40:2201–2208.
   PubMedGoogle Scholar
• Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19–28.
   PubMed Web of Science ®Google Scholar
• Sprague, G. F., Jr., and I. Herskowitz. 1981. Control of yeast cell type by the mating type locus. J. Mol. Biol. 153:305–321.
   PubMedGoogle Scholar
• Starzl, T. E., S. Todo, J. Fung, A. J. Demetris, R. Venkataramman, and A. Jain. 1989. FK-506 for liver, kidney, and pancreas transplantation. Lancet ii:1000–1004.
   Google Scholar
• Subik, J., S. Ulaszewski, and A. Goffeau. 1986. Genetic mapping of nuclear mucidin resistance mutations in Saccharomyces cerevisiae. Curr. Genet. 10:665–670.
   PubMedGoogle Scholar
• Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclo- philin. Nature (London) 337:473–475.
   PubMed Web of Science ®Google Scholar
• Tanaka, H., A. Kuroda, H. Marusawa, M. Hashimoto, H. Hatanaka, T. Kino, T. Goto, and M. Okuhara. 1987. Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant. Proc. 19:11–16.
   PubMed Web of Science ®Google Scholar
• Thomson, A. W. 1989. FK506: How much potential? Immunol. Today 10:6–9.
   Google Scholar
• Thomson, A. W. 1990. FK-506 enters the clinic. Immunol. Today 11:35–36.
   PubMedGoogle Scholar
• Tocci, M. J., D. A. Matkovich, K. A. Collier, P. Kwok, F. Dumont, S. Lin, S. Degudicibus, J. J. Siekierka, J. Chin, and N. I. Hutchinson. 1989. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 143:718–726.
   PubMed Web of Science ®Google Scholar
• Tropschug, M., I. B. Barthelmess, and W. Neupert. 1989. Sensitivity to cyclosporin A is mediated by cyclophilin ir Neurospora crassa and Saccharomyces cerevisiae. Nature (London) 342:953–955.
   PubMedGoogle Scholar
• Tropschug, M., D. W. Nicholson, F.-U. Hartl, H. Kohler, N. Pfanner, E. Wachter, and W. Neupert. 1988. Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa: one gene codes for both the cytosolic and mitochondrial forms. J. Biol. Chem. 263:14433–14440.
   PubMed Web of Science ®Google Scholar
• Tropschug, M., E. Wachter, S. Mayer, E. R. Schönbrunner, and F. X. Schmid. 1990. Isolation and sequence of an FK506-binding protein from N. crassa which catalyzes protein folding. Nature (London) 346:674–677.
   PubMed Web of Science ®Google Scholar
• Vézina, C., A. Kudelski, and S. N. Sehgal. 1975. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28:721–726.
   PubMed Web of Science ®Google Scholar
• Wiederrecht, G., L. Brizuela, K. Elliston, N. H. Sigal, and J. J. Siekierka. 1991. FKB1 encodes a nonessential FK-506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins. Proc. Natl. Acad. Sci. USA 88:1029–1033.
   PubMedGoogle Scholar
• Yoshimura, N., S. Matsui, T. Hamashima, and T. Oka. 1989. Effect of a new immunosuppressive agent, FK-506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and γ-IFN, but not B cell-stimulating factor a. Transplantation 47:356–359.
   PubMedGoogle Scholar